BACOD regimen: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 20: Line 20:


==Indications==
==Indications==
* Relapsed and refractory[[Diffuse large B-cell lymphoma]] <ref name="pmid24759015">{{cite journal| author=Gong G, Du J, Dong L, Lei W, Gao X, Fang B et al.| title=[Efficacy of adjusted BACOD regimen on the treatment of relapsed refractory diffuse large B cell lymphoma]. | journal=Zhonghua Xue Ye Xue Za Zhi | year= 2014 | volume= 35 | issue= 4 | pages= 295-9 | pmid=24759015 | doi=10.3760/cma.j.issn.0253-2727.2014.04.010 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24759015  }} </ref>
* [[Diffuse large B-cell lymphoma|Relapsed and refractory Diffuse large B-cell lymphoma]] <ref name="pmid24759015">{{cite journal| author=Gong G, Du J, Dong L, Lei W, Gao X, Fang B et al.| title=[Efficacy of adjusted BACOD regimen on the treatment of relapsed refractory diffuse large B cell lymphoma]. | journal=Zhonghua Xue Ye Xue Za Zhi | year= 2014 | volume= 35 | issue= 4 | pages= 295-9 | pmid=24759015 | doi=10.3760/cma.j.issn.0253-2727.2014.04.010 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24759015  }} </ref>


==References==
==References==

Revision as of 20:20, 27 February 2015

WikiDoc Resources for BACOD regimen

Articles

Most recent articles on BACOD regimen

Most cited articles on BACOD regimen

Review articles on BACOD regimen

Articles on BACOD regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on BACOD regimen

Images of BACOD regimen

Photos of BACOD regimen

Podcasts & MP3s on BACOD regimen

Videos on BACOD regimen

Evidence Based Medicine

Cochrane Collaboration on BACOD regimen

Bandolier on BACOD regimen

TRIP on BACOD regimen

Clinical Trials

Ongoing Trials on BACOD regimen at Clinical Trials.gov

Trial results on BACOD regimen

Clinical Trials on BACOD regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on BACOD regimen

NICE Guidance on BACOD regimen

NHS PRODIGY Guidance

FDA on BACOD regimen

CDC on BACOD regimen

Books

Books on BACOD regimen

News

BACOD regimen in the news

Be alerted to news on BACOD regimen

News trends on BACOD regimen

Commentary

Blogs on BACOD regimen

Definitions

Definitions of BACOD regimen

Patient Resources / Community

Patient resources on BACOD regimen

Discussion groups on BACOD regimen

Patient Handouts on BACOD regimen

Directions to Hospitals Treating BACOD regimen

Risk calculators and risk factors for BACOD regimen

Healthcare Provider Resources

Symptoms of BACOD regimen

Causes & Risk Factors for BACOD regimen

Diagnostic studies for BACOD regimen

Treatment of BACOD regimen

Continuing Medical Education (CME)

CME Programs on BACOD regimen

International

BACOD regimen en Espanol

BACOD regimen en Francais

Business

BACOD regimen in the Marketplace

Patents on BACOD regimen

Experimental / Informatics

List of terms related to BACOD regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: BACOD; BLEO/CTX/DM/DOX/VCR; Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine regimen

Overview

BACOD regimen refers to an immunochemotherapy regimen consisting of bleomycin, doxorubicin, cyclophosphamide ,vincristine ,dexamethasone used to treat relapsed and refractory diffuse large B cell lymphoma .[1][2]

Regimen

B – Bleomycin

A – Doxorubicin (Adriamycin)

C – Cyclophosphamide

O – Vincristine (Oncovin)

D – Dexamethasone

Indications

References

  1. "NCI Thesaurus".
  2. "R-CHOP - National Cancer Institute".
  3. Gong G, Du J, Dong L, Lei W, Gao X, Fang B; et al. (2014). "[Efficacy of adjusted BACOD regimen on the treatment of relapsed refractory diffuse large B cell lymphoma]". Zhonghua Xue Ye Xue Za Zhi. 35 (4): 295–9. doi:10.3760/cma.j.issn.0253-2727.2014.04.010. PMID 24759015.